John Washlick

John Washlick | Cozen O'Connor

Editor: Mr. Washlick, would you tell our readers something about your professional experience? Washlick: My practice focuses on commercial transactions involving healthcare organizations, including hospitals, healthcare systems, physician groups and other large healthcare providers. It runs the...

Michael Heller, Mark DeLuca, Mark Gallant, John Washlick | Cozen O'Connor

Editor: What is the current climate in the biotech/pharma industries as far as capital? Heller: Over the last year, we have seen more deal flow and venture funding. I attribute this to more optimism in the public markets, venture funds wanting to get off the sidelines as they have been for a couple...